ARCHIVES

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

ASCO Hit On Two Sides; AACR Split Criticized

June 26, 1992

Over $20 Million Carved Out From Statistical, Operations Centers

May 16, 2014

In Brief: NCI Providing Information On Levamisole To Patients; Macdonald Jins Temple, Salick

July 21, 1989

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975